Data released by the National Tumor Registry in 2014 showed that in 2010, there were 605,900 new cases of lung cancer in China, (416,300 men and 189,600 women), ranking first in malignant tumors, equivalent to 1.15 new lung cancer patients every minute, and during the same period, the number of lung cancer deaths in China was 486,600 (336,800 men and 166,200 women), accounting for The actual incidence of lung cancer is higher than the registered number because of the unbalanced economic development in China, and some people do not seek timely medical treatment, especially in the economically backward areas, even if they die of the disease, they may not be diagnosed. What is more regrettable is that 70-80% of lung cancer patients are already in advanced stage once they are found. In order to maximize the survival time, increase the survival rate, control the tumor progression and improve the quality of life of the patients, we have adopted a multidisciplinary and comprehensive treatment model.